Association Between Obstructive Sleep Apnea and Brain White Matter Hyperintensities in a Population-Based Cohort in Germany.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 10 2021
Historique:
entrez: 5 10 2021
pubmed: 6 10 2021
medline: 11 1 2022
Statut: epublish

Résumé

Underlying pathomechanisms of brain white matter hyperintensities (WMHs), commonly observed in older individuals and significantly associated with Alzheimer disease and brain aging, have not yet been fully elucidated. One potential contributing factor to WMH burden is chronic obstructive sleep apnea (OSA), a disorder highly prevalent in the general population with readily available treatment options. To investigate potential associations between OSA and WMH burden. Analyses were conducted in 529 study participants of the Study of Health in Pomerania-Trend baseline (SHIP-Trend-0) study with complete WMH, OSA, and important clinical data available. SHIP-Trend-0 is a general population-based, cross-sectional, observational study to facilitate the investigation of a large spectrum of common risk factors, subclinical disorders, and clinical diseases and their relationships among each other with patient recruitment from Western Pomerania, Germany, starting on September 1, 2008, with data collected until December 31, 2012. Data analysis was performed from February 1, 2019, to January 31, 2021. The apnea-hypopnea index (AHI) and oxygen desaturation index (ODI) were assessed during a single-night, laboratory-based polysomnography measurement. The primary outcome was WMH data automatically segmented from 1.5-T magnetic resonance images. Of 529 study participants (mean [SD] age, 52.15 [13.58] years; 282 female [53%]), a total of 209 (40%) or 102 (19%) individuals were diagnosed with OSA according to AHI or ODI criteria (mean [SD] AHI, 7.98 [12.55] events per hour; mean [SD] ODI, 3.75 [8.43] events per hour). Both AHI (β = 0.024; 95% CI, 0.011-0.037; P <.001) and ODI (β = 0.033; 95% CI, 0.014-0.051; P <. 001) were significantly associated with brain WMH volumes. These associations remained even in the presence of additional vascular, metabolic, and lifestyle WMH risk factors. Region-specific WMH analyses found the strongest associations between periventricular frontal WMH volumes and both AHI (β = 0.0275; 95% CI, 0.013-0.042, P < .001) and ODI (β = 0.0381; 95% CI, 0.016-0.060, P < .001) as well as periventricular dorsal WMH volumes and AHI (β = 0.0165; 95% CI, 0.004-0.029, P = .008). This study found significant associations between OSA and brain WMHs, indicating a novel, potentially treatable WMH pathomechanism.

Identifiants

pubmed: 34609493
pii: 2784763
doi: 10.1001/jamanetworkopen.2021.28225
pmc: PMC8493431
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2128225

Subventions

Organisme : NIA NIH HHS
ID : P30 AG066546
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG059421
Pays : United States

Références

Int J Epidemiol. 2011 Apr;40(2):294-307
pubmed: 20167617
Brain. 2008 Dec;131(Pt 12):3286-98
pubmed: 18927145
J Neurol Neurosurg Psychiatry. 2011 Feb;82(2):126-35
pubmed: 20935330
Sleep Breath. 2009 Aug;13(3):221-6
pubmed: 19067010
BMJ. 2010 Jul 26;341:c3666
pubmed: 20660506
Rofo. 2009 Aug;181(8):748-59
pubmed: 19598074
J Am Heart Assoc. 2015 Jun 23;4(6):001140
pubmed: 26104658
J Nerv Ment Dis. 2008 May;196(5):429-31
pubmed: 18477888
Alzheimers Dement. 2021 Jan;17(1):89-102
pubmed: 32920988
Alzheimers Res Ther. 2019 Jul 27;11(1):64
pubmed: 31351489
PLoS One. 2016 Jul 14;11(7):e0158758
pubmed: 27415826
Magn Reson Imaging. 2014 Sep;32(7):913-23
pubmed: 24928302
Acad Radiol. 2008 Mar;15(3):300-13
pubmed: 18280928
Neurology. 2018 Sep 4;91(10):e964-e975
pubmed: 30076276
Acad Radiol. 2013 Dec;20(12):1566-76
pubmed: 24200484
J Sleep Res. 2017 Dec;26(6):782-788
pubmed: 28548301
Alzheimers Dement (N Y). 2019 Apr 09;5:107-117
pubmed: 31011621
Neurology. 2020 Apr 28;94(17):e1793-e1802
pubmed: 32217775
J Clin Sleep Med. 2015 Dec 15;11(12):1417-24
pubmed: 26194729
Nat Rev Neurol. 2015 Mar;11(3):157-65
pubmed: 25686760
Sleep. 2013 May 01;36(5):709-715B
pubmed: 23633753
Lancet Respir Med. 2019 Aug;7(8):687-698
pubmed: 31300334
Sleep Breath. 2019 Mar;23(1):57-63
pubmed: 29564732
Metab Brain Dis. 2018 Dec;33(6):2019-2029
pubmed: 30218440
J Sleep Res. 2019 Oct;28(5):e12804
pubmed: 30565351
Brain. 2016 Apr;139(Pt 4):1164-79
pubmed: 26912649
IEEE Trans Med Imaging. 2010 Jun;29(6):1310-20
pubmed: 20378467
J Sleep Res. 2019 Oct;28(5):e12770
pubmed: 30272383
Sleep Med Rev. 2017 Aug;34:70-81
pubmed: 27568340
Sleep. 2021 Mar 12;44(3):
pubmed: 33017007
Sleep. 2016 Apr 01;39(4):785-91
pubmed: 27071695
Ther Adv Chronic Dis. 2015 Sep;6(5):273-85
pubmed: 26336596

Auteurs

Helena U Zacharias (HU)

Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.
Department of Internal Medicine I, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Institute of Clinical Molecular Biology, Kiel University and University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.

Antoine Weihs (A)

Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.

Mohamad Habes (M)

Neuroimage Analytics Laboratory and Biggs Institute Neuroimaging Core, Glenn Biggs Institute for Neurodegenerative Disorders, University of Texas Health Science Center at San Antonio, San Antonio.
Department of Radiology, University of Pennsylvania, Philadelphia.

Katharina Wittfeld (K)

Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.
German Centre for Neurodegenerative Diseases (DZNE), Site Rostock/Greifswald, Germany.

Stefan Frenzel (S)

Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.

Tanweer Rashid (T)

Neuroimage Analytics Laboratory and Biggs Institute Neuroimaging Core, Glenn Biggs Institute for Neurodegenerative Disorders, University of Texas Health Science Center at San Antonio, San Antonio.

Beate Stubbe (B)

Department of Internal Medicine B-Cardiology, Pneumology, Infectious Diseases, Intensive Care Medicine, University Medicine Greifswald, Greifswald, Germany.

Anne Obst (A)

Department of Internal Medicine B-Cardiology, Pneumology, Infectious Diseases, Intensive Care Medicine, University Medicine Greifswald, Greifswald, Germany.

András Szentkirályi (A)

Institute of Epidemiology and Social Medicine, University of Muenster, Muenster, Germany.

Robin Bülow (R)

Institute for Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Greifswald, Germany.

Klaus Berger (K)

Institute of Epidemiology and Social Medicine, University of Muenster, Muenster, Germany.

Ingo Fietze (I)

Interdisciplinary Centre of Sleep Medicine, University Hospital Charité Berlin, Berlin, Germany.

Thomas Penzel (T)

Interdisciplinary Centre of Sleep Medicine, University Hospital Charité Berlin, Berlin, Germany.

Norbert Hosten (N)

Institute for Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Greifswald, Germany.

Ralf Ewert (R)

Department of Internal Medicine B-Cardiology, Pneumology, Infectious Diseases, Intensive Care Medicine, University Medicine Greifswald, Greifswald, Germany.

Henry Völzke (H)

Institute for Community Medicine, Department Study of Health in Pomerania/Clinical Epidemiological Research, University Medicine Greifswald, Greifswald, Germany.
German Centre for Cardiovascular Research (DZHK), Partner Site Greifswald, Germany.

Hans J Grabe (HJ)

Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.
German Centre for Neurodegenerative Diseases (DZNE), Site Rostock/Greifswald, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH